WELCOME

NDC	HCPCS	HCPCS Description	NDC Label	Route of Administration
59762-4537-02	J1050	INJECTION, MEDROXYPROGESTERONE ACETATE, 1 MG	MEDROXYPROGESTERONE ACETATE 150 MG/1 ML	IM
59762-4538-01	J1050	INJECTION, MEDROXYPROGESTERONE ACETATE, 1 MG	MEDROXYPROGESTERONE ACETATE (PREFILLED SYRINGE,USP) 150 MG/ML	IM
59762-4538-02	J1050	INJECTION, MEDROXYPROGESTERONE ACETATE, 1 MG	MEDROXYPROGESTERONE ACETATE (1X1ML) strength 150 mg/1 ml	IM
59762-5091-01	J9178	INJECTION, EPIRUBICIN HCL, 2 MG	EPIRUBICIN HYDROCHLORIDE (SINGLE USE,PF) 2 MG/ML	IV
59762-5093-01	J9178	INJECTION, EPIRUBICIN HCL, 2 MG	EPIRUBICIN HYDROCHLORIDE (SINGLE USE,PF) 2 MG/ML	IV
59762-5420-01	Q0177	HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN	HYDROXYZINE PAMOATE 50 MG	PO
59762-7529-02	J9206	INJECTION, IRINOTECAN, 20 MG	IRINOTECAN HYDROCHLORIDE (1X5ML,SDV) 20 MG/ML	IV
59923-0604-02	J9185	INJECTION, FLUDARABINE PHOSPHATE, 50 MG	FLUDARABINE PHOSPHATE (1X2ML;SDV;USP) 25 MG/1 ML	IV
59923-0703-05	None	TEMODAR, 5 MG, ORAL	TEMOZOLOMIDE 5 MG	PO
59923-0704-14	None	TEMODAR, 5 MG, ORAL	TEMOZOLOMIDE 5 MG	PO
59923-0705-05	None	TEMOZOLOMIDE, 20 MG, ORAL	TEMOZOLOMIDE 20 MG	PO
59923-0706-14	None	TEMOZOLOMIDE, 20 MG, ORAL	TEMOZOLOMIDE 20 MG	PO

HCPCS Code	Description	Billing Unit	SA Type
A7005	Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable	Each	N
A7006	Administration set, with small volume filter pneumatic nebulizer	Each	N
A7007	Large voume nebulizer, disposable, unfilled, used with aerosol compressor	Each	N
A7008	Large volume nebulizer, disposable, Prefilled, used with aerosol compressor	Each	N